NYSE: CTSCts Corp Stock
$41.57-0.33 (-0.79%)
Updated Jul 14, 2025
CTS Price
$41.57
Fair Value Price
N/A
Market Cap
$1.24B
52 Week Low
$34.02
52 Week High
$59.68
P/E
20.79x
P/B
2.3x
P/S
2.42x
PEG
1.57x
Dividend Yield
0.29%
Revenue
$515.79M
Earnings
$60.36M
Gross Margin
37%
Operating Margin
15.18%
Profit Margin
11.7%
Debt to Equity
0.42
Operating Cash Flow
$96M
Beta
1.01
Next Earnings
Jul 28, 2025
Ex-Dividend
Jun 27, 2025
Next Dividend
Jul 25, 2025
CTS Overview
CTS Corporation manufactures sensors, actuators, and connectivity components in the U.S. and internationally. Its products are used in vehicles, telecommunications infrastructure, information technology, as well as in other high-speed applications in the medical, general industrial, and aerospace and defense sectors. CTS Corporation was founded in 1896 and is headquartered in Lisle, IL.
Zen Rating
Our proven quant model uses 115 proprietary factors, including AI, to determine CTS's potential to beat the market
BBuy
- Stocks with a Zen Rating of Buy (B) had an average return of +19.88% per year. Learn More
Zen Rating Component Grades
C
Zen Rating uses advanced AI algorithms that detect subtle patterns in market data; it anticipates future trends that point to superior stock price results.
Be the first to know about important CTS news, forecast changes, insider trades & much more!
CTS News
Overview
Due Diligence Score
–
Industry Average (33)
You've viewed Due Diligence Score for 10/10 free stocks. Upgrade to Premium to see how CTS scored across 38 valuation, financial, forecast, performance, and dividend due diligence checks.
Due Diligence Checks
CTS ($41.57) is trading above its intrinsic value of $20.22, according to an updated version of Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Below Benjamin Graham Formula Value Valuation
CTS is good value based on its earnings relative to its share price (20.79x), compared to the US market average (31.22x)
P/E vs Market Valuation
CTS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
There are 35 more CTS due diligence checks available for Premium users.
Valuation
CTS price to earnings (PE)
For valuing profitable companies with steady earnings
Company
20.79x
Industry
48.96x
Market
31.22x
CTS is good value based... subscribe to Premium to read more.
P/E vs Industry Valuation
CTS is good value based... subscribe to Premium to read more.
P/E vs Market Valuation
CTS price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
2.3x
Industry
5.61x
CTS is good value based... subscribe to Premium to read more.
P/B vs Industry Valuation
CTS price to earnings growth (PEG)
For valuing profitable companies with growth potential
CTS is poor value relative... subscribe to Premium to read more.
PEG Value Valuation
CTS's financial health
Profit margin
Revenue
$125.8M
Net Income
$13.4M
Profit Margin
10.6%
CTS's Earnings (EBIT) of $78.29M... subscribe to Premium to read more.
Interest Coverage Financials
CTS's profit margin has increased... subscribe to Premium to read more.
Profit Margin Growth Financials
Assets to liabilities
Assets
$765.5M
Liabilities
$227.3M
Debt to equity
0.42
CTS's short-term assets ($243.54M) exceed... subscribe to Premium to read more.
Short-term Liabilities Financials
CTS's short-term assets ($243.54M) exceed... subscribe to Premium to read more.
Long-term Liabilities Financials
CTS's debt relative to shareholder... subscribe to Premium to read more.
Shrinking Debt Financials
CTS's debt to equity ratio... subscribe to Premium to read more.
Healthy Debt to Equity Financials
Cash flow
Operating
$15.5M
Investing
-$4.5M
Financing
-$15.9M
CTS's operating cash flow ($96.50M)... subscribe to Premium to read more.
Debt Coverage Financials
CTS vs Electronic Component Stocks
Cts Stock FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.